RETA
Neuberger Berman Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-12,500
| Closed | -$1.95M | – | 1672 |
|
|
2020
Q2 | $1.95M | Hold |
12,500
| – | – | ﹤0.01% | 1001 |
|
|
2020
Q1 | $1.8M | Hold |
12,500
| – | – | ﹤0.01% | 967 |
|
|
2019
Q4 | $2.56M | Buy |
12,500
+1,300
| +12% | +$266K | ﹤0.01% | 978 |
|
|
2019
Q3 | $899K | Buy |
11,200
+4,300
| +62% | +$345K | ﹤0.01% | 1169 |
|
|
2019
Q2 | $651K | Buy |
6,900
+2,900
| +73% | +$274K | ﹤0.01% | 1237 |
|
|
2019
Q1 | $342K | Buy |
+4,000
| New | +$342K | ﹤0.01% | 1335 |
|